ID   YD-15M
AC   CVCL_L078
SY   YD15M
DR   KCLB; 60505
DR   Wikidata; Q54995384
RX   PubMed=16264262;
CC   Population: Korean.
CC   Doubling time: 20.8 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu258Ala (c.773A>C); ClinVar=VCV000458563; Zygosity=Unspecified (PubMed=16264262).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
ST   Source(s): KCLB; PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 14,19
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8930 ! YD-15
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 17
//
RX   PubMed=16264262; DOI=10.1038/emm.2005.48;
RA   Lee E.J., Kim J., Lee S.A., Kim E.-J., Chun Y.-C., Ryu M.H.,
RA   Yook J.-I.;
RT   "Characterization of newly established oral cancer cell lines derived
RT   from six squamous cell carcinoma and two mucoepidermoid carcinoma
RT   cells.";
RL   Exp. Mol. Med. 37:379-390(2005).
//